Raia Drogasil S.A. (RADLY) Research

Operating within Brazil, Raia Drogasil S.A. specializes in the retail distribution of pharmaceutical products, alongside a comprehensive range of items for personal care, beauty, perfumery, cosmetics, dermocosmetics, and specialized medications. By the end of the first quarter of 2022, specifically March 31st, its extensive operations encompassed 2,530 pharmacies located throughout 26 Brazilian states. Furthermore, the firm extends its market reach through telesales operations, supported by three dedicated contact centers situated in the states of São Paulo, Tocantins, and Pernambuco. Established in 1905, the enterprise maintains its corporate headquarters in São Paulo, Brazil.

Market snapshot

Symbol
RADLY
Price
$3.27
Day change
-6.57%
Market cap
$28.4B
P/E ratio
21.20x
52-week range
2.3-5.342
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Next earnings
in 1 month

Peer companies

  • Clicks Group Limited (CLCGY)
  • ConvaTec Group Plc (CNVVF)
  • ConvaTec Group Plc (CNVVY)
  • COSMOS Pharmaceutical Corporation (CSMYF)
  • DiaSorin S.p.A. (DSRLF)
  • Fielmann AG (FLMNF)
  • Getinge AB (publ) (GNGBY)
  • MatsukiyoCocokara & Co. (MSMKF)

Open Raia Drogasil S.A. (RADLY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.